Content area

|
|

Minimalt invasiv kirurgi til behandling af maligne lidelser i pancreas

Forfatter(e)

Kristian K. Jensen, Paul S. Krohn, Jan H. Storkholm & Stefan K. Burgdorf

Kirurgisk Afdeling C, Rigshospitalet

Ugeskr Læger 2020;182:V12190694

Reference: 
UgeskrLæger2020;182:V12190694
Blad nummer: 
Minimally invasive surgery for malignant diseases in pancreas

Kristian K. Jensen, Paul S. Krohn, Jan H. Storkholm & Stefan K. Burgdorf

Ugeskr Læger 2020;182:V12190694

Unlike most other abdominal procedures, pancreatic resection for malignant tumours is still predominantly performed as open surgery. However, recent published randomised trials suggest that a laparoscopic approach is safe and may offer advantages in the early postoperative period. Likewise, early reports of robot-assisted pancreatic resection suggest advantages. This reveiw describes the current status of minimally invasive pancreatic surgery for malignant tumours, including both laparoscopic and robot-assisted approaches for pancreaticoduodenectomy and distal pancreatectomy.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Flemming Amter | 19/10
1 Kommentar
af Henrik Dibbern | 18/10
1 Kommentar
af Jens Langhoff-Roos | 17/10
3 kommentarer
af Tomas Christensen Kjær | 16/10
1 Kommentar
af Lars Lindberg Andersen | 15/10
1 Kommentar
af Johan Tommy Robert Wallentin | 14/10
1 Kommentar
af Kristian Valbak | 11/10
2 kommentarer